Baroda BNP Paribas Dividend Yield Fund
(An open-ended equity scheme predominantly
investing in dividend yielding stocks.)
Baroda BNP Paribas Dividend Yield Fund
(An open-ended equity scheme predominantly
investing in dividend yielding stocks.)
April 2026

April 2026


Investment Objective

The investment objective is to provide medium to long term appreciation by predominantly investing in a well-diversified portfolio of equity and equity related instruments of dividend yielding companies. There is no assurance that the investment objective of the Scheme will be achieved.

NAV Details (As on April 30, 2026)
Regular IDCW : ₹ 9.4926
Regular Growth : ₹ 9.4926
Direct IDCW : ₹ 9.7384
Direct Growth : ₹ 9.7384
Benchmark Index (Tier 1)

Nifty 500 TRI

Date of Allotment

September 11, 2024

Fund Manager
Fund Manager Managing fund since Experience
Mr. Jitendra Sriram 29-Nov-25 27 years
Mr. Himanshu Singh 21-Oct-24 10 years
Load Structure

Exit Load: • If units of the Scheme are redeemed or switched out up to 10% of the units within 1 year from the date of allotment - Nil. • If units of the scheme are redeemed or switched out in excess of the limit within 1 year from the date of allotment - 1% of the applicable NAV. • If units of scheme are redeemed or switched out after 1 year from the date of allotment - Nil
For detailed load structure please refer Scheme Information Document.


Lumpsum Details

Minimum Amount: Lumpsum investment:
₹ 1,000 and in multiples of ₹ 1 thereafter.
Minimum Additional Application Amount:₹ 1,000 and in multiples of ₹ 1 thereafter.


Monthly AAUM## As on April 30, 2026 : ₹ 635.54 Crores
AUM## As on April 30, 2026 : ₹ 644.96 Crores

## including inter-scheme Investments, if any, by other schemes of Baroda BNP Paribas Mutual Fund, as may be applicable

EQUITY HOLDINGS % of Net Assets
Banks 15.77%
HDFC Bank Limited 5.38%
ICICI Bank Limited 4.33%
Kotak Mahindra Bank Limited 2.09%
State Bank of India 2.09%
Canara Bank 1.88%
Pharmaceuticals & Biotechnology 10.67%
JB Chemicals & Pharmaceuticals Limited 3.42%
Sun Pharmaceutical Industries Limited 2.52%
Divi's Laboratories Limited 2.45%
Glaxo SmithKline Pharmaceuticals Limited 2.28%
IT - Software 9.14%
Infosys Limited 2.47%
Tech Mahindra Limited 1.85%
Oracle Financial Services Software Limited 1.60%
Tata Consultancy Services Limited 1.21%
Wipro Limited 1.01%
HCL Technologies Limited 1.00%
Petroleum Products 7.59%
Reliance Industries Limited 7.59%
Auto Components 5.44%
Bharat Forge Limited 2.36%
Tenneco Clean Air India Limited 1.82%
Bosch Limited 1.26%
Construction 4.76%
Larsen & Toubro Limited 4.76%
Automobiles 4.00%
Hero MotoCorp Limited 2.35%
Eicher Motors Limited 1.65%
Food Products 3.86%
Nestle India Limited 2.26%
Britannia Industries Limited 1.60%
Electrical Equipment 3.74%
GE Vernova T&D India Limited 3.74%
Oil 3.72%
Oil India Limited 2.05%
Oil & Natural Gas Corporation Limited 1.67%
Power 3.18%
NHPC Limited 1.86%
SJVN Limited 1.32%
Finance 3.16%
Bajaj Finance Limited 1.96%
Cholamandalam Investment and Finance Company Ltd 1.20%
Non - Ferrous Metals 2.23%
National Aluminium Company Limited 2.23%
Beverages 2.10%
Radico Khaitan Limited 2.10%
Cement & Cement Products 2.10%
UltraTech Cement Limited 2.10%
Healthcare Services 1.80%
Max Healthcare Institute Limited 1.80%
Agricultural, Commercial & Construction Vehicles 1.54%
Escorts Kubota Limited 1.54%
Capital Markets 1.44%
360 One WAM Limited 1.44%
Consumer Durables 1.33%
LG Electronics India Ltd 1.33%
Diversified Metals 1.33%
Vedanta Limited 1.33%
Diversified FMCG 1.32%
ITC Limited 1.32%
Consumable Fuels 1.14%
Coal India Limited 1.14%
LESS THAN 0.75% EXPOSURE 2.36%
FUTURES LONG POSITION 1.56%
Multi Commodity Exchange of India Limited 1.56%
TOTAL EQUITY HOLDING 95.28%
FIXED INCOME HOLDINGS Rating % of Net Assets
Treasury Bill 1.54%
364 Days Tbill (MD 11/06/2026) SOV 1.54%
Total Fixed Income Holdings 1.54%
TREPS, Cash & Other Net Current Assets 3.18%
GRAND TOTAL 100.00%

Investment in Top 10 scrips constitutes 39.02% of the portfolio


For SIP Performance please click here

For Scheme Performance please click here

The scheme currently does not have Distribution History.

BER - Regular Plan (%) 2.05%
BER - Direct Plan (%) 1.01%
Portfolio Turnover Ratio 0.51

The Total Expense Ratio (TER) is the sum of the Base Expense Ratio (BER), brokerage fees, transaction costs, and statutory levies.

No of Stocks 42
Portfolio RoE (%) 21.00
EPS Growth (%) 17.18

This product is suitable for investors who are seeking*:

➤ Long term capital appreciation
➤ Investment predominantly in equity and equity related instruments of dividend yielding companies.

*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.

Scheme Riskometer^^
Investors understand that their principal will be at Very High risk


Benchmark (Tier 1) Riskometer^
Benchmark riskometer is at Very High risk


^^Riskometer For Scheme: basis it’s portfolio, ^Riskometer For Benchmark (Nifty 500 TRI): basis it’s constituents; As on April 30, 2026

For complete portfolio, kindly refer the website https://www.barodabnpparibasmf.in/
* refer Glossary page

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.